Patent · US Active

Intrathecal or epidural administration of 3-[(1S,25)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol

US8895623B2 · kind B2 · utility

0Cited by

1References

14Claims

0Family size

Assignee

Gruenenthal GmbH · DE

Inventors

Petra Bloms-Funke · Harsewinkel, DE
Derek Saunders · Aachen, DE
Eric Lang · Berling, FR

Key dates

Filing date	Jul 27, 2012
Grant date	Nov 25, 2014
Priority date	—
Expiry date	Sep 21, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/135
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a method of providing pain management in a subject wherein the administration of the composition does not result in any non-central nervous system mediated systemic effect in the subject. In particular, the present invention relates to a method of administering 3-[(1S,2S)-3-(dimethylamino)-1-ethyl-2-methyl-propyl]-phenol in a space that is void of thrombocytes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.